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Background:  The pre-transplant model for end-stage liver disease (pre-MELD) score is controversial regarding its 
ability to predict patient mortality after liver transplantation (LT).  Prominent changes in physical conditions through 
the surgery may require a post-transplant indicator for better mortality prediction. We aimed to investigate whether 
the post-transplant MELD (post-MELD) score can be a predictor of 1-year mortality. 
Methods:  Perioperative variables of 269 patients with living donor LT were retrospectively investigated on their 
association with 1-year mortality. Post-MELD scores until the 30th day and their respective declines from the 1st day 
post-MELD score were included along with pre-MELD, acute physiology and chronic health evaluation (APACHE) 
II, and sequential organ failure assessment (SOFA) scores on the 1st post-transplant day.  The predictive model of 
mortality was established by multivariate Cox’s proportional hazards regression.
Results:  The 1-year mortality rate was 17% (n = 44), and the leading cause of death was graft failure. Among 
prognostic indicators, only post-MELD scores after the 5th day and declines in post-MELD scores until the 5th and 
30th day were associated with mortality in univariate analyses (P < 0.05). After multivariate analyses, declines in 
post-MELD scores until the 5th day of less than 5 points (hazard ratio 2.35, P = 0.007) and prolonged mechanical 
ventilation ≥24 hours were the earliest independent predictors of 1-year mortality.
Conclusions:  A sluggish decline in post-MELD scores during the early post-transplant period may be a meaningful 
prognostic indicator of 1-year mortality after LT.  (Korean J Anesthesiol 2010; 59: 160-166)
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Introduction
    Liver transplantation (LT) is usually has higher mortality 
rates than other types of surgery due to acute hepatic failure, 
graft size-related problems, ischemic time, original disease 
recurrence, cardiovascular complications, and infection [1-3].
    Early determination of mortality factors are important 
for proper patient management using pre-transplant or 
intraoperative factors [4,5]. One prognostic marker is the model 
for end-stage liver disease (MELD) score, which was originally 
developed for predicting early mortality in patients waiting for 
LT [6]. Patients with higher MELD scores usually have more 
preoperative comorbidities and laboratory abnormalities, 
so pre-transplant MELD (pre-MELD) score can help predict 
pre-transplant fatal outcomes [7]. Despite controversy [8], the 
pre-MELD score is not generally a useful indicator of post-
transplant mortality or in pre-transplant situations [9].
    Patients after LT have much different physical conditions 
than pre-transplant periods. Graft-related problems cause 
more than 50% percent of late deaths [2]. MELD score is based 
primarily on liver-related laboratory findings such as bilirubin 
and international normalized ratio of prothrombin time (INR). 
Therefore, patients with changed liver conditions should receive 
a new MELD score. MELD score is partly driven by creatinine 
and can reflect post-transplant deterioration in renal function 
as well. Although pre-transplant renal dysfunction improves 
after transplantation [10], LT also leads to chronic renal disease, 
which can contribute to graft and patient survival [11].
    Clearly, pre-transplant cross-sectional assessment of 
disease severity is important in predicting patient outcomes. 
However, re-evaluation or follow-up observation in the early 
post-transplant period may be more valuable for accurate 
prediction of long-term outcomes after surgery. Studies on 
post-transplant MELD (post-MELD) scores are rare, although it 
may be a predictor for short-term mortality [12,13]. An initially 
high MELD score in the immediate post-transplant period may 
decrease, increase, or remain unchanged according to recipient 
recovery patterns, which may also inform patient prognosis. 
    Although the MELD score system is invaluable and widely 
used for patients with end-stage liver disease for its convenience 
and simplicity, other prognostic indicators for critically ill 
patients in an intensive care unit (ICU) may be useful, such 
as acute physiology and chronic health evaluation (APACHE) 
II and sequential organ failure assessment (SOFA) scoring 
systems, which are used for mortality prediction from cirrhosis 
in the ICU patients [14-16]. Comparing the predictive ability of 
MELD scores and these ICU severity scores may be useful.
    We therefore investigated whether changes in MELD scores 
or other ICU severity scores in the early post-transplant period 
were associated with mortality in LT recipients. 
Materials and Methods
    We collected perioperative and survival data in LT patients 
from November, 2003, to August, 2008, after approval of the 
Institutional Review Board at our university. Only adult (≥18 
years) living donor LT cases were included. Transplantation was 
performed between the right hepatic lobes of both recipient 
and donor. Perioperative patient management was guided by 
routine LT protocols at our hospital. The electrical medical 
recoding system and chart system of the Transplantation Center 
at our hospital were used for this collection. The end point of 
this study was 1-year mortality after transplantation, and we 
studied the following variables.
    Recipient pre-transplant variables: age, Child-Pugh-Turcott 
(CPT) class C, MELD score, emergency surgery, heart disease 
history, hepatorenal syndrome, hepatic encephalopathy, 
ascites (≥1 L), alanine aminotransferease (ALT) level, and 
hyponatremia (Na
+ < 130 mmol/L).
    Recipient intraoperative variables: last lactate concentration, 
packed red cell transfusion, reperfusion syndrome, and surgery 
time.
    Donor variables: age, graft macrosteatosis ≥20%, graft recipient 
weight ratio (GRWR).
    Recipient post-transplant variables (within 7 days after surgery): 
reoperation, infection, pulmonary complication, low urine 
output (<1 ml/kg/h), prolonged mechanical ventilation (≥24 
hours), APACHE II score, SOFA score on the 1
st post-transplant 
day.
    Post-MELD scores were calculated on the 1st, 3rd, 5th, 7th, 
14th, and 30th post-transplant day, using the formula: R = 9.6 
× loge (creatinine mg/dl) + 3.8 × loge (bilirubin mg/dl) + 11.20 
× loge INR + 6.4, as reported by Kamath et al. [17]. Declines in 
post-MELD scores from the 1
st day post-MELD score until the 
3
rd (D3), 5
th (D5), 7
th (D7), 14
th (D14), 30
th post-transplant day (D30) 
were also calculated.
Statistical methods
    Predictive factors for mortality after LT were analyzed by 
Cox’s proportional hazards regression model. Relative risks 
were calculated as proportional hazard ratio (HR) for each 
probable perioperative variable in a univariate model. Before 
multivariate analyses, selected continuous variables (P < 0.05) 
were dichotomized at their median, at clinically meaningful 
cutoff points, or at the point with maximal sensitivity and 
specificity for mortality by the analysis of area under the 
Receiver Operating Characteristic (ROC) curve. We performed 
multivariate analyses using a forward and backward stepwise 
Cox’s regression model with the likelihood ratio test statistic. 
Results by multivariate analyses were displayed as HR, 95% 162 www.ekja.org
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confidence interval (CI), and P-value. Two side P values less 
than 0.05 were considered statistically significant. SPSS version 
15.0 for Windows (SPSS Inc, Chicago, IL, USA) was used for 
most statistical analyses and ROC curve analysis was conducted 
using MEDCALC for Windows version 11.0 (MedCalc Software, 
Mariakerke, Belgium).
Results
    Of 281 patients who underwent LT during the study period, 
269 patients were included, with exclusions of 9 cadaver 
donations and 3 pediatric cases. Baseline demographics of LT 
recipients and donors are shown in Table 1. More recipients 
(11%) were older than 60 years than donors (1.5%). Recipients 
were predominantly male, and 56.1% had liver cirrhosis 
resulting from hepatitis B virus infection. Mean MELD scores 
of the recipients was 18.8 points at the pre-transplant period, 
and increased to 20.6 points just after transplantation. MELD 
scores then declined by more than 7 points until the 5th post-
transplant day. 
    The 1-year mortality rate of LT recipients was 17.1% (n = 41). 
Eighteen (43.9%) deaths were associated with graft failure, 
Table 2.  Hazard Ratios for Mortality after Liver Transplantation According to Perioperative Variables
Variables β HR 95% CI P value
Pre-transplant
  Age (yr)
  Child-Pugh-Turcott class C (Y/N)
  Emergency surgery (Y/N)
  Heart disease (Y/N)
  Ascites ≥1 L (Y/N)
  Hepatorenal syndrome (Y/N)
  Hepatic encephalopathy (Y/N)
  Alanine aminotransferease (U/L)
  Hyponatremia (Y/N)
Intraoperative
  Last lactate concentration (mmol/L)
  Packed red cell transfusion (units)
  Reperfusion syndrome (Y/N)
  Surgery time (min)
Donor
  Age (years)
  Graft macrosteatosis ≥20% (Y/N)
  Graft recipient weight ratio (%)
Post-transplant
  Reoperation (Y/N)
  Infection (Y/N)
  Pulmonary complication (Y/N)
  Low urine output (<1 ml/kg/hr) (Y/N)
  Prolonged mechanical ventilation = 24 hours (Y/N)
  APACHE II score (pts)*
  SOFA score (pts)
†
0.01
-0.43
0.61
-0.08
-0.36
0.16
-0.38
0.01
0.20
0.07
0.02
0.09
0.09
-0.01
-0.64
-0.11
1.12
-0.31
0.95
0.60
1.74
-0.12
-0.22
1.01
0.65
1.84
0.93
0.70
1.17
0.68
1.00
1.22
1.07
1.02
1.09
1.09
0.99
0.53
0.89
3.06
0.74
2.58
1.83
5.72
0.89
0.80
0.98-1.01
0.35-1.21
0.72-4.69
0.33-2.60
0.35-1.39
0.46-2.99
0.44-1.06
0.99-1.02 
0.30-5.07
1.00-1.16
0.98-1.05
0.15-7.96
0.90-1.32
0.97-1.03
0.13-2.19
0.17-4.66
1.46-6.42
0.39-1.38
1.32-5.06
0.91-3.66
2.92-11.21
0.78-1.01
0.65-1.00
0.550
0.176
0.201
0.887
0.307
0.736
0.086
0.601
0.781
0.058
0.820
0.929
0.381
0.941
0.379
0.893
0.003
0.340
0.006
0.089
<0.001
0.068
0.047
CI: confidence interval, HR: hazard ratio. *Acute physiology and chronic health evaluation score on the 1st post-transplant day, 
†Sequential 
organ failure assessment score on the 1st post-transplant day.
Table 1.  Baseline Demographics of Recipients and Donors with Liver 
Transplantation 
Recipients (n = 269)
  Age (yr)
  Gender, M/F (%)
  Body mass index (kg/m
2)
  Diagnosis
    Hepatitis B cirrhosis
    Hepatocellular carcinoma with cirrhosis
    Acute fulminant hepatic failure 
    Alcoholic cirrhosis
  Pre-transplant MELD score (pts)
  Post-transplant MELD score (pts) 
    On the 1st day
    On the 3rd day
    On the 5th day
    On the 7th day
    On the 14th day
    On the 30th day
  Hypertension
  Diabetes
Donors (n = 269)
  Age (yr)
  Gender, M/F (%)
  Body mass index (kg/m
2)
49.0 ± 9.1
  71.4/28.6
23.9 ± 3.0
151 (56.1)
  97 (36.1)
  29 (10.8)
21 (7.8)
18.8 ± 8.5
20.6 ± 6.1
15.0 ± 6.8 
13.2 ± 5.4
11.9 ± 5.6
10.4 ± 6.0
   9.9 ± 5.9
24 (8.9)
  56 (20.8)
  33.5 ± 11.2
  64.9/35.1
23.3 ± 2.8
Data are presented as mean ± SD or number (%), MELD: model for 
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and infectious complications such as pneumonia or sepsis 
were the second most common cause of death (n = 14, 34.1%). 
Cancer recurrence or metastasis (14.6%), cardiac problems 
(9.8%), bleeding (7.3%), suicide (4.9%), and renal failure (2.5%) 
followed as causes of death. The incidence of death cases with 
more than one cause of death was 26.8%, including multi-
organ failure (7.3%). In univariate analysis, no pre-transplant, 
intraoperative, or donor variables were associated with 
mortality. Only post-transplant variables such as reoperation, 
pulmonary complication, prolonged mechanical ventilation 
≥24 hours until the 7th post-transplant day, and SOFA score on 
the 1st post-transplant day were related to 1-year mortality after 
LT (P < 0.05, Table 2). 
    The association of MELD score related variables with 
mortality is displayed in Table 3. Pre-MELD and post-MELD 
scores on the 1st and 3rd day had no influence on 1-year 
mortality. After the 5th post-transplant day, all post-MELD 
scores had meaningful associations with 1-year mortality (P < 
0.05). Changes in MELD score did not show a relationship with 
mortality. Only D5 and D30 were significant (P < 0.05), and could 
enter the next multivariate analyses. The cutoff point of D5 
with the maximal combination of sensitivity and specificity for 
mortality by ROC curve analysis was 5 points.
    Through multivariate analysis, we could establish a predictive 
model of mortality that included post-transplant prolonged 
mechanical ventilation ≥24 hours and decline in post-MELD 
score (Table 4). No post-MELD scores were significant in the 
final multivariate analysis. Instead, D5 less than 5 points was 
identified as the earliest independent predictor of 1-year 
mortality in living donor LT (HR 2.35, 95% CI 1.27-4.68, P = 
0.007). 
    Post-MELD declines reflect 1-year mortality, as shown in 
the survival graph (Fig. 1). Patients with D5 less than 5 points 
showed significantly lower 1-year mortality than patients with 
D5 higher than 5 points (74.1% vs 88.4%, P = 0.004).
Discussion
    The MELD score was adopted for the organ allocation 
system in the United States in 2002, and was originally 
designed to assess the short-term mortality of patients with 
portal hypertension undergoing transjugular intrahepatic 
portosystemic shunt [6]. However, its simplicity to calculate 
and inclusion of important items have increased its use for 
predicting intraoperative or post-transplant outcomes as well 
as pre-transplant complications in patients who underwent LT. 
In addition to predicting the three month mortality of patients 
on LT waiting lists [18], a MELD score higher than 30 points 
Table 3.  Hazard Ratios for Mortality after Liver Transplantation According to Model for End-stage Liver Disease (MELD) Scores 
Variables β HR 95% CI P value Cutoff point* 
Pre-transplant MELD score (pts)
Post-transplant MELD score (pts)
  On the 1
st day
  On the 3
rd day
  On the 5
th day
  On the 7
th day
  On the 14
th day
  On the 30
th day
Decline in post-transplant MELD score (pts)
† 
  Until the 3
rd day (D3)
  Until the 5
th day (D5)
  Until the 7
th day (D7)
  Until the 14
th day (D14)
  Until the 30
th day (D30)
0.01
-0.02
-0.02
0.06
0.05
0.05
0.15
-0.02
-0.04
-0.03
-0.03
-0.10
1.01
0.99
0.98
1.07
1.05
1.05
1.16
0.99
0.96
0.97
0.97
0.91
0.97-1.04
0.94-1.04
0.93-1.03
1.01-1.13
1.00-1.09
1.01-1.09
1.12-1.20
0.94-1.04
0.93-0.99
0.93-1.00
0.94-1.00
0.88-0.94
0.785
0.568
0.427
0.017
0.034
0.008
<0.001
0.568
0.044
0.062
0.074
<0.001
13
11
  8
11
  5
  1
CI: confidence interval, HR: hazard ratio, *By the analysis of the area under receiver operating characteristic (ROC) curve, 
†Difference from the 
MELD score on the 1st post-transplant day. 
Table 4.  Predictive Model for Mortality after Living Donor Liver Transplantation by Multivariate Cox’s Proportional Hazards Regression Model
β HR 95% CI P value
Post-transplant prolonged mechanical 
  ventilation ≥24 hours
D5* less than 5 points
1.69
0.89
5.43
2.35
 2.77 -10.67
1.27-4.68
<0.001
0.007
*Decline in post-transplant model for end-stage liver disease score from the 1st day until the 5th post-transplant day.164 www.ekja.org
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indicates higher requirements for intraoperative transfusion 
and vasopressors [19,20]. However, pre-MELD score is not 
sufficiently reliable as a predictor of mortality [21,22]. This study 
also indicated pre-MELD score did not predict post-transplant 
mortality.
    LT Patients have different pre-transplant and post-transplant 
situations. In particular, transplanted liver graft and immune 
suppression are critical for patient management and prognosis 
[23], with infection, recurrence of primary liver disease, and 
side effects of immunosuppressants playing critical roles in 
mortality [2,3,24]. Pre-transplant factors may help predict post-
transplant mortality [4,25], but the survival of LT recipients 
depends on immunological or functional recovery of the liver 
graft. 
    Causes of mortality after LT are categorized as either graft-
related or non-graft related. The main cause for graft-related 
mortality is recurrence of primary disease or hepatitis virus, 
and for non-graft related mortality is a cardiovascular event or 
de novo malignancy [2]. The riskiest time period for mortality 
is the first post-transplant year, particularly the first three 
months [26,27], with primary causes of mortality that include 
graft dysfunction, technical problems, and infection [28]. Graft-
related deaths cause more than half of all mortality. Graft failure 
in cadaveric donor LT is influenced by donor age, donation after 
cardiac death, and split/partial grafts [29]. Living donor LT may 
have other risk predictors for graft failure, including small size 
discrepancy for metabolic requirements, or vascular problems 
resulting from thrombosis, or mechanical twisting because of 
smaller sizes. Liver graft evaluation and prediction system for 
early post-transplant may therefore be more useful than pre-
transplant ones. 
    The MELD score is a good indicator of liver graft status 
because it measures bilirubin, INR, and renal function, and 
is simple to calculate. Pre-transplant renal dysfunction with 
estimated glomerular filtration rates <30 ml/min/1.73 m
2 is 
often restored after LT, but immunosuppression frequently 
induces chronic kidney diseases [10]. Post-transplant kidney 
disease is a common complication after LT and impacts graft 
and patient survival [11,30]. A pre-MELD score ≥20 points had 
a higher incidence of post-LT chronic renal failure and higher 
mortality rate [31]. We therefore assessed post-MELD scores 
for comparison with other mortality indicators [32], and it was 
reliable in predicting short-term mortality at less than 90 days 
[12,13]. 
    We showed that the post-MELD score could predict long-
term mortality (1 year), but the pre-MELD score did not. Graft-
related problems were the leading cause of death, so post-
MELD score may reflect these graft-related problems. Renal 
failure did not contribute to death as much as we expected, and 
perioperative variables were not associated with mortality. 
    APACHE II scores, SOFA score, simplified acute physiology 
score (SAPS), and multiple organ dysfunction score (MODS) 
are ICU severity scoring systems used in mortality prediction 
[33,34]. In cirrhotic patients, SOFA score has been compared to 
other ICU severity scores, including APACHE II, failing organ 
systems (FOS), organ system failure (OSF), and liver specific 
scores including Child-Pugh-Turcott classification and MELD 
score [15,16]. SOFA was the most accurate predictor of mortality 
through analysis of the area under the ROC curves, but 
requires follow-up measurement. The score at 48 h after ICU 
admission or mean scores of multiple measurements are better 
than baseline scores on ICU admission day. APACHE II can 
also predict mortality in LT patients [14], although it tends to 
overestimate mortality rate in LT patients. We used 1-day post-
transplant SOFA or APACHE II scores to capture the earliest 
indicator of mortality [35]. However, SOFA score showed a 
negative correlation with the mortality, potentially because the 
poor clinical condition on day 1 makes those scores less useful 
for determining mortality. Follow-up ICU scores after the 1
st 
post-transplant day may improve the predictive power of these 
tests and should include more patients.
    The prognostic model of mortality in this study included 
prolonged mechanical ventilation during the ICU period after 
LT, which is a known risk factor for mortality after LT [36]. 
Intraoperative variables such as blood loss, urine volume, 
and postoperative renal failure may contribute to prolonged 
mechanical ventilation [37]. We developed a post-MELD for 
testing mortality at 1 year, and that included bilirubin and 
creatinine to measure early renal or allograft failure [32]. The 
MELD scores after the 5
th post-transplant day showed the best 
Fig. 1. Comparison of survival rates between patients with and 
without D5 less than 5 points. The patients with D5 less than 5 points 
show a significantly lower 1-year survival rate than those without 
D5 less than 5 points (74.1% vs 88.4%; P = 0.004, by log-rank test in 
Kaplan-Meier analysis). D5: decline in post-transplant MELD score 
from the 1st day until the 5th post-transplant day.165 www.ekja.org
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mortality prediction, which was much earlier than 14
th day post-
MELD scores used previously [13]. Furthermore, we measured 
changes in MELD score over time. A sluggish decline in MELD 
score indicates slow recovery or a failing graft. After adjustment 
for other confounding factors, the sequential observation 
of MELD scores had better prognostic ability than static 
assessment on a designated post-transplant day. In particular, a 
decline <5 points (from the 1
st day post-MELD score) until the 
5
th post-transplant day is the earliest predictor of mortality after 
LT.
    This study has some inherent limitations as a retrospective 
study. Incomplete data was substituted with medians, but 
the patient population was small. A differentiated approach 
according to LT diagnosis (e.g. cirrhosis versus cancer) or 
cause of death might improve clinical application of the results. 
However, the use of 1-year mortality rates and changing post-
MELD scores over time are important contribution of the study.
    In conclusion, the post-MELD score could reflect 1-year 
mortality after LT, whereas pre-MELD, APACHE II, and SOFA 
scores did not. In particular, a sluggish decline in the post-
MELD score of less than 5 points until the 5th day (from the 1st 
day post-MELD score) is the earliest independent predictor of 
1-year mortality after LT. 
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